Imad M. Tleyjeh

72.3k total citations · 2 hit papers
113 papers, 6.9k citations indexed

About

Imad M. Tleyjeh is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Imad M. Tleyjeh has authored 113 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Infectious Diseases, 59 papers in Epidemiology and 27 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Imad M. Tleyjeh's work include Infective Endocarditis Diagnosis and Management (31 papers), COVID-19 Clinical Research Studies (25 papers) and Streptococcal Infections and Treatments (24 papers). Imad M. Tleyjeh is often cited by papers focused on Infective Endocarditis Diagnosis and Management (31 papers), COVID-19 Clinical Research Studies (25 papers) and Streptococcal Infections and Treatments (24 papers). Imad M. Tleyjeh collaborates with scholars based in United States, Saudi Arabia and Canada. Imad M. Tleyjeh's co-authors include Larry M. Baddour, James M. Steckelberg, Walter R. Wilson, Walter R. Wilson, Patrick T. O’Gara, Michael J. Rybak, Kathryn A. Taubert, Bruno Baršić, Anne Fink and Matthew E. Levison and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Imad M. Tleyjeh

110 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications

2015 1.9k citations Larry M. Baddour, Imad M. Tleyjeh et al. profile →
Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis

2022 345 citations Muhammad Riaz, Dana Gerberi et al. Clinical Microbiology and Infection profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Imad M. Tleyjeh United States	42	4.0k	3.0k	1.7k	1.4k	1.4k	113	6.9k
Stefano Bassetti Switzerland	36	1.1k 0.3×	1.9k 0.6×	408 0.2×	1.8k 1.3×	786 0.6×	159	5.6k
Benoît Misset France	47	2.5k 0.6×	1.5k 0.5×	791 0.5×	396 0.3×	648 0.5×	163	7.2k
André C. Kalil United States	44	5.0k 1.3×	2.3k 0.8×	566 0.3×	276 0.2×	719 0.5×	169	9.1k
Ignacio Martín‐Loeches Ireland	56	7.0k 1.7×	2.3k 0.8×	700 0.4×	508 0.4×	1.0k 0.8×	369	12.9k
Stephen O. Heard United States	38	2.6k 0.7×	1.5k 0.5×	1.1k 0.7×	798 0.6×	2.4k 1.8×	133	11.8k
Hervé Dupont France	46	1.5k 0.4×	1.7k 0.5×	570 0.3×	1.1k 0.8×	2.2k 1.6×	214	7.1k
Brian D. Lahr United States	52	3.8k 1.0×	838 0.3×	851 0.5×	2.0k 1.4×	3.4k 2.5×	245	8.7k
Marc Léone France	54	3.2k 0.8×	996 0.3×	472 0.3×	1.9k 1.4×	3.3k 2.5×	402	10.8k
Chien‐Chang Lee Taiwan	45	2.2k 0.6×	771 0.3×	602 0.3×	635 0.4×	1.5k 1.1×	272	6.5k
Margaret A. Olsen United States	47	2.8k 0.7×	2.4k 0.8×	739 0.4×	762 0.5×	3.7k 2.7×	268	8.7k

Countries citing papers authored by Imad M. Tleyjeh

Since Specialization

Citations

This map shows the geographic impact of Imad M. Tleyjeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Imad M. Tleyjeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Imad M. Tleyjeh more than expected).

Fields of papers citing papers by Imad M. Tleyjeh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Imad M. Tleyjeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Imad M. Tleyjeh. The network helps show where Imad M. Tleyjeh may publish in the future.

Co-authorship network of co-authors of Imad M. Tleyjeh

This figure shows the co-authorship network connecting the top 25 collaborators of Imad M. Tleyjeh. A scholar is included among the top collaborators of Imad M. Tleyjeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Imad M. Tleyjeh. Imad M. Tleyjeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tleyjeh, Imad M.. (2023). Which trial do we need? Comparison of 7 versus 14 days of antibiotic therapy for ventilator-associated pneumonia due to highly resistant gram-negative bacteria. Clinical Microbiology and Infection. 29(9). 1114–1116.

Sharif‐Askari, Fatemeh Saheb, Imad M. Tleyjeh, Narjes Saheb Sharif‐Askari, et al.. (2022). Sotrovimab Lowers the Risk of COVID‐19 Related Hospitalization or Death in a Large Population Cohort in the United Arab Emirates. Clinical Pharmacology & Therapeutics. 112(6). 1214–1223. 6 indexed citations

Alasmari, Faisal, et al.. (2022). Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study. PLoS ONE. 17(8). e0272818–e0272818.

Omrani, Ali S. & Imad M. Tleyjeh. (2021). Which are the best coronavirus disease 2019 vaccines?. Clinical Microbiology and Infection. 27(12). 1729–1732. 1 indexed citations

Ahmed, Ahmed Ibrahim, Yushui Han, Talal Alnabelsi, et al.. (2021). The prognostic role of cardiac positron emission tomography imaging in patients with sarcoidosis: A systematic review. Journal of Nuclear Cardiology. 28(4). 1545–1552. 12 indexed citations

Ramakrishnan, Rakhee K., Tarek Kashour, Qutayba Hamid, Rabih Halwani, & Imad M. Tleyjeh. (2021). Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19. Frontiers in Immunology. 12. 686029–686029. 159 indexed citations

Kashour, Tarek, Aref A. Bin Abdulhak, Haytham Tlayjeh, et al.. (2020). Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Mortality Among COVID-19 Patients: A Systematic Review and Meta-Analysis. American Journal of Therapeutics. 30(4). e336–e346. 5 indexed citations

Kashour, Zakariya, Muhammad Riaz, Musa A. Garbati, et al.. (2020). Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy. 76(1). 30–42. 95 indexed citations

Tleyjeh, Imad M., Zakariya Kashour, Moussab Damlaj, et al.. (2020). Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis. Clinical Microbiology and Infection. 27(2). 215–227. 127 indexed citations

10.

DeSimone, Daniel C., Imad M. Tleyjeh, Daniel D. Correa de, et al.. (2015). Incidence of Infective Endocarditis Due to Viridans Group Streptococci Before and After the 2007 American Heart Association’s Prevention Guidelines. Mayo Clinic Proceedings. 90(7). 874–881. 49 indexed citations

11.

Tleyjeh, Imad M., Aref A. Bin Abdulhak, Muhammad Riaz, et al.. (2013). Correction: The Association between Histamine 2 Receptor Antagonist Use and Clostridium difficile Infection: A Systematic Review and Meta-analysis. PLoS ONE. 8(4). 4 indexed citations

12.

Khan, Abdur Rahman, Aref A. Bin Abdulhak, Mujeeb Sheikh, et al.. (2013). Device Closure of Patent Foramen Ovale Versus Medical Therapy in Cryptogenic Stroke. JACC: Cardiovascular Interventions. 6(12). 1316–1323. 80 indexed citations

13.

Alasmari, Faisal, Imad M. Tleyjeh, Muhammad Riaz, et al.. (2012). Temporal Trends in the Incidence of Surgical Site Infections in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Population-Based Cohort Study, 1993 to 2008. Mayo Clinic Proceedings. 87(11). 1054–1061. 18 indexed citations

14.

Garbati, Musa A., Faisal Alasmari, Mohamad Al‐Tannir, & Imad M. Tleyjeh. (2011). The role of combination antifungal therapy in the treatment of invasive aspergillosis: a systematic review. International Journal of Infectious Diseases. 16(2). e76–e81. 41 indexed citations

15.

Khan, Abdur Rahman, Sobia Khan, Valerie Zimmerman, Larry M. Baddour, & Imad M. Tleyjeh. (2010). Quality and Strength of Evidence of the Infectious Diseases Society of America Clinical Practice Guidelines. Clinical Infectious Diseases. 51(10). 1147–1156. 77 indexed citations

16.

Assiri, Abdullah M., Faisal Alasmari, Valerie Zimmerman, et al.. (2009). Corticosteroid Administration and Outcome of Adolescents and Adults With Acute Bacterial Meningitis: A Meta-analysis. Mayo Clinic Proceedings. 84(5). 403–409. 4 indexed citations

17.

Baddour, Larry M., et al.. (2008). Q Fever Endocarditis: The Mayo Clinic Experience. The American Journal of the Medical Sciences. 336(1). 53–57. 20 indexed citations

18.

McNamara, David, Imad M. Tleyjeh, Elie F. Berbari, et al.. (2007). Incidence of Lower-Extremity Cellulitis: A Population-Based Study in Olmsted County, Minnesota. Mayo Clinic Proceedings. 82(7). 817–821. 50 indexed citations

19.

Al‐Mallah, Mouaz H., Imad M. Tleyjeh, Ahmed Abdel‐Latif, & W. Douglas Weaver. (2006). Angiotensin-Converting Enzyme Inhibitors in Coronary Artery Disease and Preserved Left Ventricular Systolic Function. Journal of the American College of Cardiology. 47(8). 1576–1583. 108 indexed citations

20.

Tleyjeh, Imad M., et al.. (2005). Cytomegalovirus cholangitis presenting with recurrent hemobilia. European Journal of Clinical Microbiology & Infectious Diseases. 24(9). 634–636. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact